Healthcare Analysts discuss emerging treatment options for High-Rick Non-Muscle Invasive Bladder Cancer (NMIBC) (relevant companies ENGN CGON JNJ IBRX TARA) on an Analyst/Industry conference call to be held on September 10.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENGN: